MediWound Ltd

NASDAQ:MDWD  
1.27
-0.01 (-0.78%)
5:37:25 PM EDT: $1.28 +0.01 (+0.79%)
Earnings Announcements

Mediwound Reports Q3 Net Loss Of $0.13 Per Share

Published: 11/15/2022 12:36 GMT
MediWound Ltd (MDWD) - Mediwound Reports Third Quarter 2022 Financial Results and Provides Company Update.
Qtrly $30.5 Million in Gross Proceeds Raised; Operating Cash Runway Through 2025.
Total Revenues for Q3 of 2022 Were $5.8 Million Compared to $6.4 Million in Q3 of 2021.
Qtrly Net Loss per Share $0.13.
Q4 Earnings per Share View $-0.08, Revenue View $4.8 Million -- Refinitiv Ibes Data (analyst estimates).
Nexobrid PDUFA Date of January 1, 2023; Upon Approval, Nexobrid Expected to Generate Meaningful Revenues.
Escharex Phase 3 Clinical Study to Begin in First-half 2023.
Revenue is expected to be $4.91 Million
Adjusted EPS is expected to be -$0.10

Next Quarter Revenue Guidance is expected to be $11.36 Million
Next Quarter EPS Guidance is expected to be -$0.05

More details on our Analysts Page.